Also seek prompt care for withdrawal symptoms, especially if they include tremors, seizures, severe vomiting, dehydration, or unstable vital signs
Exceptional safety margin No dependence or tolerance naturally occurring endogenous peptide Tolerability in clinical trials No tolerance develops with repeated doses No withdrawal symptoms upon stopping Peptide naturally present in the human body Research considerations Researcher's notes Outstanding safety profile for a bioactive peptide No serious adverse events were reported in the published studies
Amphetamines manipulate the levels of certain neurotransmitters in the central nervous system (CNS) and the peripheral nervous system (PNS)
Youssoufian, H., Longmore, G., Neumann, D., Yoshimura, A